Osaic Holdings
NVAX icon

Osaic Holdings’s Novavax NVAX Stock Holding History

Osaic Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2
Closed -$5K – 7553
2022
Q4 		$5K Hold
2
– – ﹤0.01% 6294
2022
Q3 		$4K Hold
2
– – ﹤0.01% 6500
2022
Q2 		$2K Hold
2
– – ﹤0.01% 6909
2022
Q1 		$1K Buy
+2
New +$178 ﹤0.01% 7084

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings's NVAX Position: Q1 2026 in Review

Osaic Holdings increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $19.4K and bringing the position to 47,943 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Osaic Holdings first reported a position in NVAX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Osaic Holdings held 47,943 shares of Novavax worth $390K as of Q1 2026.
  • Osaic Holdings bought 2,142 Novavax shares in Q1 2026, an estimated $19.4K.
  • Novavax made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3590 holding.
  • Osaic Holdings first reported a position in Novavax in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Novavax position peaked at $10.7M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.